ChinaDaily Briefs

Daily Brief China: Tencent, Jinke Smart Services, Swire Pacific (B), Vipshop Holdings, Poly Real Estate Group Co., Ltd, Medlive Technology, Road King Infrastructure and more

In today’s briefing:

  • Tencent Investee Selldown – The US$120bn Global Overhang
  • Jinke Smart (9666 HK)’s Low-Balled But Virtually Unconditional Offer
  • Swire B Vs A – Surprising on Regs, Surprising on Risk; Short-Tm Displacement Now in 99th Percentile
  • Jinke Smart’s VGO of HK$12.00 from Boyu Capital
  • Tencent Increases Its Investment in Medical and Healthcare
  • Vipshop: Rebound in Chinese Apparel Sales Should Trump Conservative Management Guidance
  • FTSE China A50 Index Rebalance Preview: Tight Margins
  • Medlive Technology (2192.HK) 22H1- The Growth Logic/Business Model Is More Scrutinized by the Market
  • Morning Views Asia: Road King Infrastructure

Tencent Investee Selldown – The US$120bn Global Overhang

By Sumeet Singh

  • Multiple new agencies have been reporting that Tencent (700 HK) plans to trim its investment portfolio over the remainder of the year. 
  • The reports have been coming in since the second half of the year and the company has been duly denying these rumors.
  • In this note, we look at Tencent’s shareholding in various companies to try and gauge which ones it could sell out of and how.

Jinke Smart (9666 HK)’s Low-Balled But Virtually Unconditional Offer

By David Blennerhassett

  • PRC-Incorporated property management play Jinke Smart Services (9666 HK) has announced a voluntary cash offer at HK$12/share, a 33.04% premium to last close.
  • The Offeror (Boyu) and concert parties collectively hold more than 50%. The Offer is contingent on regulatory approvals and 7.71% of shares out tendering. The tendering condition can be waived.
  • The Offer appears geared to bring Boyu’s stake in line with Jinke Property Group (000656 CH)‘s. 

Swire B Vs A – Surprising on Regs, Surprising on Risk; Short-Tm Displacement Now in 99th Percentile

By Travis Lundy

  • The Swire buyback has been impressive. In 27 trading days they have bought back 26.8% of teh HK$4bn promised. In that period, participation has been aggressive.
  • Swire has bought back As at a pace of 52% of pre-buyback one-year ADV. For Bs, it has been 105%. But Bs have dramatically underperformed As on “HK Re-opening” trades.
  • Historically, when B/A gets more than 6% from 3mo Avg VWAP Ratio, there is statistically significant reversion. We are now at 6.8%. I’d buy B vs A.

Jinke Smart’s VGO of HK$12.00 from Boyu Capital

By Arun George

  • Jinke Smart Services (9666 HK) announced a voluntary conditional general offer from Boyu Capital at HK$12.00 per share, a 33.0% premium to the undisturbed price.
  • The offer is conditional on 7.71% valid acceptances (such that Boyu represents 30.40% of outstanding shares) and anti-trust approval. The conditions can be waived.  
  • The offer is designed to flush out minorities unwilling to wait for the industry headwinds to dissipate. A low threshold suggests that the offer will be declared unconditional.

Tencent Increases Its Investment in Medical and Healthcare

By Shifara Samsudeen, ACMA, CGMA

  • Tencent known to outspend its peers on strategic investments, has made only around 80 investments and acquisitions so far this year compared to more than 200 deals done in 2021.
  • Tencent’s vast investment portfolio has attracted regulatory scrutiny and it’s the market’s belief that Tencent was asked to divest some of its stake in other leading tech players in China.
  • However, over the last few months, Tencent has been increasingly investing on companies operating in the medical field.

Vipshop: Rebound in Chinese Apparel Sales Should Trump Conservative Management Guidance

By Wium Malan, CFA

  • Following a contraction in Chinese apparel sales since 3Q21, and similar negative GMV and product revenue growth for Vipshop, we have witnessed a recovery to growth since June.
  • Current sell-side forecasts are, however, still for a -10.8%y/y contraction in product revenue for Vipshop in 3Q22f, followed by a -4.4% contraction in 4Q22f which seems overly pessimistic.
  • Given the conservative nature of near-term top-line growth expectation, and management guidance, the probability for positive earnings surprise seems high.

FTSE China A50 Index Rebalance Preview: Tight Margins

By Brian Freitas

  • Poly Real Estate Group Co., Ltd (600048 CH) sits at the edge of the inclusion zone for the FTSE China A50 Index (XIN9I INDEX) December rebalance.
  • That inclusion could result in the deletion of any one of four stocks since they are all clustered within 0.7% of each other on full market cap.
  • There are a few other stocks that are close to inclusion zone and a 5-10% rally in these stocks could result in more changes to the index in December.

Medlive Technology (2192.HK) 22H1- The Growth Logic/Business Model Is More Scrutinized by the Market

By Xinyao (Criss) Wang

  • The improvement of Medlive’s profitability in 22H1 seems more related to the large decreased income tax expense rather than any obvious improvement of main business or any other logic.
  • The single main business structure and insufficient core competitiveness add uncertainty to the Company’s long-term prospects, which makes it difficult to significantly improve the valuation.
  • Medlive is under double pressure of “squeezing bubble” in healthcare industry and “the fading of traffic dividend” in Internet industry.Its growth logic/business model will be more scrutinized by the market.

Morning Views Asia: Road King Infrastructure

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars